This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Seddon classification of nerve injuries

Authoring team

Sir Herbert Seddon in 1942 described a scheme for describing nerve injuries according to the extent of damage to axons and surrounding connective tissue layers. It has clinical relevance in that it indicates the likely prognosis:

  • neuropraxia:
    • no anatomical disruption
    • a localised, physiological and transient conduction block along a nerve
    • usually a result of a blunt injury
    • no distal Wallerian degeneration occurs
    • very variable, but often a motor paralysis with some residual sensory or autonomic function
    • nerve conduction studies show a conduction block at the level of the injury
    • typically, there is recovery in days to weeks
    • a diagnosis of exclusion
  • axonotmesis:
    • axonal damage within the nerve
    • axonal degernation but endoneurial tubes and surrounding connective tissue elements remain intact
    • distal Wallerian degeneration
    • often the result of a more intensive blunt injury
    • full recovery is usual but may take weeks to months; there may be a residual deficit
  • neurotmesis:
    • nerve divided
    • usually violent, open injuries
    • all axons and connective tissue elements disrupted
    • Wallerian degeneration distally
    • some recovery possible but much more likely with surgical nerve repair
    • full recovery unlikely

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.